Clinical Trial Update: S0029 Docetaxel in Treating Older Women With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

This ClinicalTrials.gov entry reports the termination of a Phase 2 study evaluating docetaxel in older women with metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED